IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Lonza Acquires Cell Discovery Technology Firm

11:23 AM MDT | June 2, 2008 | Deepti Ramesh

Lonza says it has acquired Amaxa (Cologne, Germany), a technology supplier to the cell discovery market, for an undisclosed amount. The transaction is subject to anti-trust regulatory approval, which is expected to take place early in the third quarter, Lonza says. Amax provides high-end nucleic acid transfection systems and consumables to academic institutions and pharmaceutical and biotechnology businesses, Lonza says. Amaxa also has proprietary technologies in the niche transfection systems market. “Amaxa is an excellent fit with the Lonza Bioscience...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa